Not applicableUnknownNCT05561998What this trial is testingTalking Mats as Decision Aid for Older People Living With Mild to Moderate DementiaWho this might be right forMild to Moderate Dementia Göteborg University 100
Not applicableStudy completedNCT03536975What this trial is testingIdentify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases and Their Primary CaregiversWho this might be right forCognitive Impairment, MildDementia, Mild University Hospital, Rouen 48
Post-approval studies (Phase 4)Study completedNCT07417670What this trial is testingSatisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's DiseaseWho this might be right forAlzheimer Disease Carnot Laboratories 105
Testing effectiveness (Phase 2)UnknownNCT03038035What this trial is testingThe Alzheimer's Disease THErapy With NEuroaid (ATHENE) StudyWho this might be right forAlzheimer Disease National University Hospital, Singapore 150
Large-scale testing (Phase 3)Study completedNCT03986424What this trial is testingLocal Study of Akatinol Memantine in VaD in RussiaWho this might be right forVascular Dementia Merz Pharmaceuticals GmbH 130
Testing effectiveness (Phase 2)Ended earlyNCT00916617What this trial is testingStudy Evaluating The Long-Term Safety And Efficacy Of Subcutaneous BapineuzumabWho this might be right forAlzheimer Disease Pfizer 62
Large-scale testing (Phase 3)WithdrawnNCT01211782What this trial is testingAC-1204 Long-term Efficacy Response Trial (ALERT Protocol)Who this might be right forAlzheimer's Disease Cerecin
Testing effectiveness (Phase 2)UnknownNCT01569516What this trial is testingStudy of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Changchun Huayang High-tech Co., Ltd 288
Early research (Phase 1)Study completedNCT01850238What this trial is testingSafety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's DiseaseWho this might be right forAlzheimer Disease Axon Neuroscience SE 30
Early research (Phase 1)Study completedNCT05667649What this trial is testingAutologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Regeneration Biomedical, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT03305809What this trial is testingLY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)Who this might be right forLewy Body Dementia Eli Lilly and Company 344
Early research (Phase 1)WithdrawnNCT03316898What this trial is testingA FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Allergan
Not applicableStudy completedNCT01796314What this trial is testingImpact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of LifeWho this might be right forAlzheimer Disease University Hospital, Toulouse 170
Large-scale testing (Phase 3)Study completedNCT02453932What this trial is testingEfficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular DementiaWho this might be right forVascular Dementia Dongzhimen Hospital, Beijing 543
Large-scale testing (Phase 3)Study completedNCT00053599What this trial is testingCholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyWho this might be right forAlzheimer Disease National Institute on Aging (NIA) 400
Early research (Phase 1)Study completedNCT02434718What this trial is testingSingle and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Biogen 21
Testing effectiveness (Phase 2)Study completedNCT00566397What this trial is testingStudy Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 402
Testing effectiveness (Phase 2)Study completedNCT02626572What this trial is testingEfficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive SymptomsWho this might be right forAlzheimer's Disease Institut de Recherches Internationales Servier 500
Large-scale testing (Phase 3)Temporarily pausedNCT04520412What this trial is testingSodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 2,046
Early research (Phase 1)Study completedNCT00736775What this trial is testingThe Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Genentech, Inc. 56